Özdemir, A. Et Al. 2022. Malignancy rates and risk factors in Bethesda category IV thyroid nodules: Is lobectomy enough in an endemic region?. JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , vol.39, no.3 , 749-754.

Özdemir, A., Uyan, M., Kalcan, S., Çolakoğlu, M. K., & Pergel, A., (2022). Malignancy rates and risk factors in Bethesda category IV thyroid nodules: Is lobectomy enough in an endemic region?. JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , vol.39, no.3, 749-754.

Özdemir, ALİ Et Al. "Malignancy rates and risk factors in Bethesda category IV thyroid nodules: Is lobectomy enough in an endemic region?," JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , vol.39, no.3, 749-754, 2022

Özdemir, ALİ Et Al. "Malignancy rates and risk factors in Bethesda category IV thyroid nodules: Is lobectomy enough in an endemic region?." JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , vol.39, no.3, pp.749-754, 2022

Özdemir, A. Et Al. (2022) . "Malignancy rates and risk factors in Bethesda category IV thyroid nodules: Is lobectomy enough in an endemic region?." JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , vol.39, no.3, pp.749-754.

@article{article, author={ALİ ÖZDEMİR Et Al. }, title={Malignancy rates and risk factors in Bethesda category IV thyroid nodules: Is lobectomy enough in an endemic region?}, journal={JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE}, year=2022, pages={749-754} }